Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Argent Biopharma ( (AU:RGT) ) has provided an announcement.
Argent Biopharma Limited announced the issuance of 2,252,381 ordinary fully paid securities to creditors as a substitute for cash payments. This strategic move aims to manage financial obligations while maintaining liquidity, potentially impacting the company’s financial stability and stakeholder confidence.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
Average Trading Volume: 98,425
Technical Sentiment Signal: Sell
Current Market Cap: A$8.68M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.